Chorus Ltd
OTC:CHRYY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Chorus Ltd
OTC:CHRYY
|
NZ |
|
Verona Pharma PLC
NASDAQ:VRNA
|
UK |
|
Lynch Group Holdings Ltd
ASX:LGL
|
AU |
|
R
|
Rio Tinto PLC
F:RIO1
|
UK |
Wall St Price Targets
CHRYY Price Targets Summary
Chorus Ltd
According to Wall Street analysts, the average 1-year price target for
CHRYY is 27.46 USD with a low forecast of 24.52 USD and a high forecast of 31.04 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CHRYY's stock price target?
Price Target
27.46
USD
According to Wall Street analysts, the average 1-year price target for
CHRYY is 27.46 USD with a low forecast of 24.52 USD and a high forecast of 31.04 USD.
What is the Revenue forecast for Chorus Ltd?
Projected CAGR
3%
Over the last 12 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Chorus Ltd?
Projected CAGR
6%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Chorus Ltd?
Projected CAGR
19%
Over the last 12 years, the compound annual growth rate for Operating Income has been -3%. The projected CAGR for the next 3 years is 19%.
What is the Pre-Tax Income forecast for Chorus Ltd?
Projected CAGR
102%
Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been -18%. The projected CAGR for the next 3 years is 102%.
What is the Net Income forecast for Chorus Ltd?
Projected CAGR
208%
Over the last 12 years, the compound annual growth rate for Net Income has been -27%. The projected CAGR for the next 3 years is 208%.